According to Vertex Pharmaceuticals's latest financial reports the company's total assets are $22.73 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $22.73 B | 25.23% |
2022-12-31 | $18.15 B | 35.13% |
2021-12-31 | $13.43 B | 14.3% |
2020-12-31 | $11.75 B | 41.27% |
2019-12-31 | $8.31 B | 33.18% |
2018-12-31 | $6.24 B | 76.14% |
2017-12-31 | $3.54 B | 22.41% |
2016-12-31 | $2.89 B | 15.94% |
2015-12-31 | $2.49 B | 7.02% |
2014-12-31 | $2.33 B | 0.67% |
2013-12-31 | $2.31 B | -15.96% |
2012-12-31 | $2.75 B | 25.18% |
2011-12-31 | $2.20 B | 27.75% |
2010-12-31 | $1.72 B | -11.76% |
2009-12-31 | $1.95 B | 99.44% |
2008-12-31 | $0.98 B | 63.01% |
2007-12-31 | $0.60 B | -34.73% |
2006-12-31 | $0.92 B | 67.87% |
2005-12-31 | $0.54 B | 0.65% |
2004-12-31 | $0.54 B | -24.7% |
2003-12-31 | $0.72 B | -11.19% |
2002-12-31 | $0.81 B | -11.83% |
2001-12-31 | $0.92 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $171.96 B | 656.55% | ๐บ๐ธ USA |
AbbVie ABBV | $134.71 B | 492.65% | ๐บ๐ธ USA |
Gilead Sciences GILD | $62.12 B | 173.31% | ๐บ๐ธ USA |
Merck MRK | $106.67 B | 369.31% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $99.03 B | 335.68% | ๐บ๐ธ USA |
Enanta Pharmaceuticals
ENTA | $0.42 B | -98.11% | ๐บ๐ธ USA |